FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors
FORTIS
250.4
-2.15 (-0.85%)
Updated 01:26 30/07 IST
FORTIS Buy or Sell - FrontPage Forums
2 Users have submitted 2 trade ideas of Rs. 251,350 for FORTIS
Disclaimer100% Bullish
0% Bearish
FORTIS Buy or Sell - Brokerage Reports
No. of reports in last year
0
No. of analysts
0
Average Consensus Forecast
Consensus Potential
0.00%
FORTIS Ratings
Long term FORTIS rating by FrontPage users
- ★★
- ★★
- ★★
- ★★
- ★★
0/5 (0 Ratings)0
Find answers to all your questions on live FORTIS message board: Is FORTIS buy or sell? Should I buy FORTIS shares? Why are FORTIS shares falling? Should I invest in FORTIS stock?
- Home
- FORTIS Forum
FORTIS Share Price Discussion
S
Reputation: 4,056 • Jul 26 2:51 AM
26-07-2021
BUY FORTIS --> NSE (Positional Short-MID Term)
Only Above @ 248.70
**SL & TGT only for premium members**
Like
Reply (2)
See all replies
high 251 🔥🔥🔥🔥🚀🚀🤑🤑🤑
FORTIS - High 257 🔥🔥🔥🚀🚀🚀🤑🤑🤑 3.33% Up 🚀🤑🤑💥 **Premium channel call**
N
Reputation: 15,707 • Jul 21 5:21 AM
Delhi Police files fresh FIR against Malvinder and Shivinder for Rs 400 crore 'fraud'
According to the FIR, Malvinder and Shivinder Singh, the former promoters of Fortis, have allegedly duped the company of over ₹crore, siphoning off the money for personal gain and to pay off their loans. “Enquiry has substantiated allegations of the complainant wherein promoters in conspiracy with their associates indulged in criminal breach of trust and criminal misappropriation by diverting the funds of the company,” the FIR says.
According to the FIR, Malvinder and Shivinder Singh, the former promoters of Fortis, have allegedly duped the company of over ₹crore, siphoning off the money for personal gain and to pay off their loans. “Enquiry has substantiated allegations of the complainant wherein promoters in conspiracy with their associates indulged in criminal breach of trust and criminal misappropriation by diverting the funds of the company,” the FIR says.
The Economic Times
Like
Reply
N
Reputation: 15,707 • Jul 16 1:46 AM
Private hospitals struggle with drastic fall in Covid immunisation
They need to put in a request on the portal and pay in advance, after which an approval comes from the vaccine manufacturers. No supply date is shared with the hospitals.
They need to put in a request on the portal and pay in advance, after which an approval comes from the vaccine manufacturers. No supply date is shared with the hospitals.
The Economic Times
Like
Reply
Join FrontPage
FrontPage is India's favorite stock discussions community
Join 2,00,000 Indian traders and discuss trades, strategies, news & views on any stock.
- keyboard_arrow_down
FORTIS Share Price - Technicals
- NewsBotJul 21 5:21 AMDelhi Police files fresh FIR against Malvinder and Shivinder for Rs 400 crore 'fraud'The Economic TimesNewsBotJul 16 1:46 AMPrivate hospitals struggle with drastic fall in Covid immunisationThe Economic TimesNewsBotJul 8 1:36 AM
Rising long Covid cases a new worry for hospitalsThe Economic TimesNewsBotJun 29 2:11 AM
Russian made COVID-19 vaccine Sputnik V's commercial launch delayedThe Economic TimesNewsBotJun 22 1:21 AM
How Work From Home culture is changing the face of workThe Economic TimesNewsBotJun 22 11:06 AM
Jhunjhunwala says commodity cycle has just begun; steel rally not overThe Economic TimesNewsBotJun 18 1:31 AM
Fortis to offer Sputnik V vaccineThe Economic TimesNewsBotJun 18 1:16 AM
Hospitals start process to get Johnson & Johnson vaccine from EU quotaThe Economic TimesNewsBotJun 17 11:11 AM
Fortis Healthcare says COVID vaccines protected 92% vaccinated healthcare workersThe Economic TimesNewsBotJun 16 12:06 PM
Select midcaps expected to buck Covid 2.0 bluesThe Economic Times
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and FrontPage will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein.